Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival
Open Access
- 16 April 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (16), 3773-3780
- https://doi.org/10.1182/blood-2008-09-177469
Abstract
CD19 and CD20 are B cell–specific antigens whose expression is heterogeneous when analyzed by flow cytometry (FCM). We determined the association between CD20 expression and clinical outcome in patients with diffuse large B-cell lymphoma (DLBCL). The mean fluorescence intensity of CD20 and CD19 was determined by FCM, and the cytoplasmic expression of CD20 was determined by immunohistochemistry (IHC) on 272 diagnostic DLBCL samples. Exon 5 of the MS4A1 gene coding for the extracellular component of the CD20 antigen was sequenced in 15 samples. A total of 43 of 272 (16%) samples had reduced CD20 expression by FCM; of these, 35 (13%) had bright CD19 expression. The latter had a markedly inferior survival when treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or rituximab-CHOP (R-CHOP; median survival of 1.2 and 3.0 years vs not reached for the others, P < .001 and P = .001), independent of the International Prognostic Index. A total of 41 of 43 samples with reduced CD20 expression by FCM had strong staining for CD20 by IHC. There were no mutations in exon 5 of the MS4A1 gene to explain the discrepancy between FCM and IHC. CD20 and CD19 expression by FCM should be determined on all biopsies of patients with DLBCL because reduced CD20 expression cannot be reliably detected by IHC.This publication has 51 references indexed in Scilit:
- First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trialBlood, 2008
- Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patientsBritish Journal of Haematology, 2008
- Lipid rafts and B cell signalingSeminars in Cell & Developmental Biology, 2007
- Calcium signalling in lymphocyte activation and diseaseNature Reviews Immunology, 2007
- Performance of calibration standards for antigen quantitation with flow cytometry in chronic lymphocytic leukemiaCytometry Part B: Clinical Cytometry, 2007
- The epitope recognized by rituximabBlood, 2006
- Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomasBlood, 2006
- A Quantitative Exploration of Surface Antigen Expression in Common B-Cell Malignancies Using Flow CytometryImmunological Investigations, 2006
- A cholesterol-dependent CD20 epitope detected by the FMC7 antibodyLeukemia, 2003
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000